The strategy of combined use of copeptin and cTn, besides serving as a diagnostic tool, could identify patients with chest pain at higher risk for adverse events and the development of heart failure (HF) very early after symptom onset, thus enabling early triage decision. The gene discussed is AVP; the disease is hydrops fetalis.